{
    "clinical_study": {
        "@rank": "138002", 
        "arm_group": {
            "arm_group_label": "Probing, topical anesthesia", 
            "description": "Nasolacrimal duct obstruction (NLDO) is a quite common condition among the infants. An imperforate membrane at the distal end of the nasolacrimal duct is the main cause of occlusion. Children with the signs of NLDO presenting with epiphora and/or mucous discharge were included in this study. Intervention with probing under topical anesthesia was performed on the same surgeon. And success rate was evaluated."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to investigate various potential factors that affected the\n      outcome of treatment of congenital nasolacrimal duct obstruction."
        }, 
        "brief_title": "The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Congenital Nasolacrimal Duct Obstruction", 
        "detailed_description": {
            "textblock": "Congenital nasolacrimal duct obstruction is a common condition during the first few years of\n      childhood. Most cases may resolve spontaneously, but the remaining children whose blockage\n      does not resolve may require primary probing. Controversy remains regarding the optimal\n      timing of the probing procedure. Another controversy is related to the setting of surgery.\n      Therefore, we try to investigate the factors that affected the outcome of treatment of\n      congenital nasolacrimal duct obstruction under the same surgical doctor during the past 13\n      years in our hospital."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  a history of tearing and/or mucopurulent discharge beginning during the first few\n             weeks of life\n\n          -  anatomical nasolacrimal duct obstruction\n\n        Exclusion Criteria:\n\n          -  previous probing\n\n          -  glaucoma\n\n          -  trauma\n\n          -  lid malpositions\n\n          -  craniofacial anomalies\n\n          -  congenital mucocele of the nasolacrimal sac"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081781", 
            "org_study_id": "CGH-P103002"
        }, 
        "intervention": {
            "arm_group_label": "Probing, topical anesthesia", 
            "description": "A punctal dilator was used for dilating the punctum. The nasolacrimal system was irrigated through either the lower or upper punctum with a hollow 23-gauge irrigating cannula attached to a syringe. A #0 (or #00) Bowman probe was passed through either the lower or upper canaliculus into the lacrimal sac and then directed downward through the nasolacrimal duct into nasal cavity. A \"Hard\" resistance could be felt as the probe touched the end of the nasolacrimal duct. A \"Pop\" tactile sensation might be noted while the probe passing through an obstruction at the valve of Hasner.", 
            "intervention_name": "Probing", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "106"
                }, 
                "name": "Department of Ophthalmology, Cathay General Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Case Control Study of the Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction", 
        "overall_official": {
            "affiliation": "Department of Ophthalmology, Cathay General Hospital", 
            "last_name": "Chih Heng Hung, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "probing success: both anatomical patency of the duct and functional free of symptoms", 
            "safety_issue": "No", 
            "time_frame": "one week"
        }, 
        "reference": [
            {
                "PMID": "17996306", 
                "citation": "Pediatric Eye Disease Investigator Group; Repka MX, Chandler DL, Beck RW, Crouch ER 3rd, Donahue S, Holmes JM, Lee K, Melia M, Quinn GE, Sala NA, Schloff S, Silbert DI, Wallace DK. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology. 2008 Mar;115(3):577-584.e3. Epub 2007 Nov 8."
            }, 
            {
                "PMID": "24568978", 
                "citation": "Miller AM, Chandler DL, Repka MX, Hoover DL, Lee KA, Melia M, Rychwalski PJ, Silbert DI; Pediatric Eye Disease Investigator Group. Office probing for treatment of nasolacrimal duct obstruction in infants. J AAPOS. 2014 Feb;18(1):26-30. doi: 10.1016/j.jaapos.2013.10.016."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081781"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cathay General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cathay General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}